Cargando…
Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
SIMPLE SUMMARY: Triple Negative Breast Cancer represents a cancer type with an unmet clinical need. This type of breast cancer presents the worse clinical outcome due to its aggressiveness, high heterogeneity, and absence of therapeutic targets. Chemotherapy is still the standard of care for this ty...
Autores principales: | Mahmoud, Rinad, Ordóñez-Morán, Paloma, Allegrucci, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454775/ https://www.ncbi.nlm.nih.gov/pubmed/36077812 http://dx.doi.org/10.3390/cancers14174280 |
Ejemplares similares
-
Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
por: Yang, Fang, et al.
Publicado: (2016) -
Triple-negative breast cancer: treatment challenges and solutions
por: Collignon, Joëlle, et al.
Publicado: (2016) -
Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018) -
Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022) -
Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman, Michael L, et al.
Publicado: (2015)